Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4 pseudogene 34 is a nuclear-encoded pseudogene related to the mitochondrial gene for NADH dehydrogenase subunit 4 (MT-ND4). Unlike its functional mitochondrial counterpart (MT-ND4), this pseudogene does not encode a protein and does not participate in oxidative phosphorylation, disease pathogenesis, or represent a viable drug target. There are many MT-ND4-related pseudogenes annotated in the human genome, and they are considered non-coding and non-functional in a therapeutic or biomarker context. MT-ND4 is the gene for mitochondrially encoded NADH dehydrogenase 4, a subunit of mitochondrial respiratory chain complex I, with clear biological and clinical importance (in cases such as Leber hereditary optic neuropathy). Pseudogenes like MTND4P34 are non-functional copies/paralogs of genuine genes, often found scattered throughout the nuclear genome and do not encode active proteins nor serve therapeutic purposes. There is no evidence for MTND4P34 functioning as a receptor, enzyme, transporter, or biomarker. If a query involves "MT-ND4 pseudogene 34" as a drug target, receptor, or biomarker, it is incorrect: this is not a viable molecular target and does not have roles in disease or drug action. If you meant the actual mitochondrial ND4 protein (complex I component), that is a well-characterized therapeutic and diagnostic target—please clarify if you need information on that instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4 pseudogene 34 (MTND4P34).